Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like After a decade of drought: Are investments going back to medical devices? March 22, 2018 Call for companies to present their activities in MIXiii-BIOMED 2018 (Hebrew) March 25, 2018 MIXiii-BIOMED 2018: Introducing the Best of Israel’s Life Science Innovations April 3, 2018
